All Insights
Showing 313 - 324 of 7984
Regulatory Outlook
Environment, social and governance | UK Regulatory Outlook November 2024
Sustainable supply chains drive international success | Autumn Budget 2024 | Updates made to the UK's retail disclosure regime
Regulatory Outlook
Competition | UK Regulatory Outlook November 2024
Merger remedies approach to be reviewed | Booking.com removes all parity clause in EEA | UK-EU cooperation agreement
Regulatory Outlook
Sanctions and Export Control | UK Regulatory Outlook November 2024
Changes to sanctions legislation | New sanctions package against Russia | OFSI and OFAC two-year enhanced partnership anniversary
Regulatory Outlook
Consumer Law | UK Regulatory Outlook November 2024
Secondary legislation made under Media Act 2024 | Culture, Media and Sport Committee re-launches British film and high-end TV inquiry
Regulatory Outlook
Data Law | UK Regulatory Outlook November 2024
Progress of the Data (Use and Access) Bill | ICO prioritising work to protect children online | ICO publishes report
Regulatory Outlook
Bribery, fraud and anti-money laundering | UK Regulatory Outlook November 2024
Failure to prevent fraud guidance published
Regulatory Outlook
Health and Safety | UK Regulatory Outlook November 2024
Terrorism (Protection of Premises) Bill completes Commons Committee stage | Higher Risk Buildings: confusion over whether a roof garden counts
Regulatory Outlook
Modern Slavery | UK Regulatory Outlook November 2024
EU Regulation prohibiting products in the Union market made using forced labour receives final approval
Regulatory Outlook
Advertising and marketing | UK Regulatory Outlook November 2024
Government introduces Tobacco and Vapes Bill to Parliament: advertising aspects | ASA publishes update on its vaping project review |
Regulatory Outlook
Cyber Security | UK Regulatory Outlook November 2024
ENISA draft technical guidance on NIS2 cyber security risk management measures | DSIT call for evidence on Cyber Security and
Life Sciences and Healthcare
EU enforces stricter liability for life sciences products
Pharma and medtech companies face enhanced liability under the EU's new directive
Future of work
What is the scope of the obligation for companies in Spain to have equality and non-discrimination policies for LGBT persons?
All companies with more than 50 employees should carefully evaluate their situation after the approval of the regulation
